Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Solid Tumors
Interventions: BIOLOGICAL: MT110
Sponsor: Amgen Research (Munich) GmbH